
LOGIN / SKAPA KONTO
Aktuellt
SUMMARY Palliative care should be offered together with disease-modifying therapies, to meet physical, psychosocial, social and spiritual needs. ERS SATELITTE 2026 COPD:...
Addressing treatable traits important part of precision medicine in COPD Breakthroughs in COPD care are not always dramatic innovations but often consist...
SUMMARY At this year’s ERS Satellite, Professor Surya Bhatt presented a compelling update on the evolving diagnostic paradigm in chronic obstructive pulmonary...
SUMMARY The focus of COPD management should be shifted towards primary prevention, argues Professor Gappa, as a growing body of evidence points...
SUMMARY In summary: Asthma is a complex disease worsened by comorbidities like CRSwNP, GERD, OSA, and obesity, which share inflammatory pathways and...
SUMMARY COPD is an increasingly important cause of morbidity, disability and mortality worldwide. Environmental risk factors are important to address for future...
SUMMARY Preschool wheeze is a heterogenous condition with multiple underlying pathophysiological mechanisms that result in similar clinical manifestations. Frequent severe exacerbations is...
SUMMARY It is essential to understand the beliefs and decisions that drive behaviour and decision-making around self-management of asthma. What can influence...
SUMMARY Spoiler alert: it is not! You are probably not surprised if you are meeting people living with COPD in health care....

Chiesi är ett familjeägt läkemedelsföretag grundat 1935. Vi tror på innovation, ansvarstagande och mänsklig empati. Vår passion är att förbättra livskvaliteten för patienter världen över genom forskning, utveckling och hållbara lösningar.
© 2026 Chiesi Pharma AB. Denna webbplats riktar sig till hälso-och sjukvårdspersonal i Sverige.






